Pearlie K. Burnette

Person

Tampa, FL, US

People

Patents Grantslast 30 patents

Information Patent Grant
Dimeric immuno-modulatory compounds against cereblon-based mechanisms
- Patent number 11,730,726
- Issue date Aug 22, 2023
- H. Lee Moffitt Cancer Center & Research Institute, Inc.
- Pearlie Burnette
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Small molecules against cereblon to enhance effector t cell function
- Patent number 11,395,820
- Issue date Jul 26, 2022
- H. Lee Moffitt Cancer Center & Research Institute, Inc.
- Pearlie Burnette
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods using HDAC11 inhibitors
- Patent number 10,538,496
- Issue date Jan 21, 2020
- Forma Therapeutics, Inc.
- Jennifer Lee
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
CD28 expression during lenalidomide immune modulation
- Patent number 10,241,113
- Issue date Mar 26, 2019
- H. Lee Moffitt Cancer Center & Research Institute, Inc.
- Pearlie Burnette
- G01 - MEASURING TESTING
Information Patent Grant
Biomarkers for predicting response to immunosuppressive therapy
- Patent number 9,176,122
- Issue date Nov 3, 2015
- University of South Florida
- Pearlie K. Burnette
- G01 - MEASURING TESTING

Patents Applicationslast 30 patents

Information Patent Application
DIMERIC IMMUNO-MODULATORY COMPOUNDS AGAINST CEREBLON-BASED MECHANISMS
- Publication number 20240165095
- Publication date May 23, 2024
- H. Lee Moffitt Cancer Center & Research Institute, Inc.
- Pearlie Burnette
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SMALL MOLECULES AGAINST CEREBLON TO ENHANCE EFFECTOR T CELL FUNCTION
- Publication number 20230226035
- Publication date Jul 20, 2023
- H. Lee Moffitt Cancer Center & Research Institute, Inc.
- Pearlie Burnette
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
DIMERIC IMMUNO-MODULATORY COMPOUNDS AGAINST CEREBLON-BASED MECHANISMS
- Publication number 20220362229
- Publication date Nov 17, 2022
- H. Lee Moffitt Cancer Center & Research Institute, Inc.
- Pearlie Burnette
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SMALL MOLECULES AGAINST CEREBLON TO ENHANCE EFFECTOR T CELL FUNCTION
- Publication number 20210177825
- Publication date Jun 17, 2021
- H. Lee Moffitt Cancer Center & Research Institute, Inc.
- Pearlie Burnette
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS USING HDAC11 INHIBITORS
- Publication number 20190084946
- Publication date Mar 21, 2019
- Forma Therapeutics, Inc.
- Jennifer Lee
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS USING HDAC11 INHIBITORS
- Publication number 20180127386
- Publication date May 10, 2018
- Forma Therapeutics, Inc.
- Jennifer Lee
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CD28 EXPRESSION DURING LENALIDOMIDE IMMUNE MODULATION
- Publication number 20150276741
- Publication date Oct 1, 2015
- H. Lee Moffitt Cancer Center & Research Institute, Inc.
- Pearlie Burnette
- G01 - MEASURING TESTING
Information Patent Application
TELOMERASE REVERSE TRANSCRIPTASE DEFICIENCY AS DIAGNOSTIC MARKER OF...
- Publication number 20150005250
- Publication date Jan 1, 2015
- H. Lee Moffitt Cancer Center & Research Institute, Inc.
- Dana E. Rollison
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
BIOMARKERS FOR PREDICTING RESPONSE TO IMMUNOSUPPRESSIVE THERAPY
- Publication number 20110091481
- Publication date Apr 21, 2011
- University of South Florida
- Pearlie K. Burnette
- G01 - MEASURING TESTING

Pearlie K. Burnette

Person

Patents Grantslast 30 patents

Dimeric immuno-modulatory compounds against cereblon-based mechanisms

Small molecules against cereblon to enhance effector t cell function

Methods using HDAC11 inhibitors

CD28 expression during lenalidomide immune modulation

Biomarkers for predicting response to immunosuppressive therapy

Patents Applicationslast 30 patents

DIMERIC IMMUNO-MODULATORY COMPOUNDS AGAINST CEREBLON-BASED MECHANISMS

SMALL MOLECULES AGAINST CEREBLON TO ENHANCE EFFECTOR T CELL FUNCTION

DIMERIC IMMUNO-MODULATORY COMPOUNDS AGAINST CEREBLON-BASED MECHANISMS

SMALL MOLECULES AGAINST CEREBLON TO ENHANCE EFFECTOR T CELL FUNCTION

METHODS USING HDAC11 INHIBITORS

METHODS USING HDAC11 INHIBITORS

CD28 EXPRESSION DURING LENALIDOMIDE IMMUNE MODULATION

TELOMERASE REVERSE TRANSCRIPTASE DEFICIENCY AS DIAGNOSTIC MARKER OF...

BIOMARKERS FOR PREDICTING RESPONSE TO IMMUNOSUPPRESSIVE THERAPY